Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
CLYM

Updated 10/6/2026, 8:11 AM ET.

CLYM

Climb Bio, Inc.

Sale$1,366,820

Thomas Stephen Basil

Director

100,000 shat $13.67Filed Sep 17, 4:15 PM ET
Filing

Read from public SEC filings. Not financial advice.